Clinical trials
Congenital Hearing Loss clinical trials
Below are recruiting congenital hearing loss clinical trials, each written for real people, not researchers. We’re tracking 22 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07024524Recruiting
Hearing evaluation and rehab system for congenital hearing loss
This study is developing a system to evaluate and improve hearing for people with congenital hearing loss. It compares participants who have hearing loss (and have used hearing aids, cochlear implants, or gene therapy) with healthy controls, to better understand and treat hearing challenges.
ShanghaiAges 1–35 - NCT05788536RecruitingPhase 1/Phase 2
Gene therapy study for OTOF-related hearing loss
This trial tests a one-time gene therapy delivered into the ear to improve hearing in people with certain OTOF gene changes. It studies safety and how well the treatment can work, especially in children and infants, as doctors monitor hearing tests for up to 48 weeks.
Los Angeles, CaliforniaAges Any age - NCT05775367Recruiting
Cochlear implants for young children with one-sided deafness
This study checks whether cochlear implants help young children (ages about 7 months to under 3 years) who have very severe hearing loss in one ear. It also compares them with similar children who do not get implants, to understand what outcomes to expect.
Durham, North CarolinaAges 7 months–5.9 years - NCT05808543Recruiting
BEARS training to improve hearing skills in teens with two implants
This study tests a structured training program (BEARS) designed to help children and teenagers who use cochlear implants in both ears hear better in everyday life. It aims to improve hearing abilities by building on your implant settings and usual care.
Birmingham, BirminghamAges 8–16 - NCT06174038Recruiting
Hearing aids for memory and hearing loss study
This study tests whether hearing aids can help people with both hearing loss and early memory problems. It lasts for a period of time, and you will be asked to wear hearing aids daily.
New York, New YorkAges 55–75 - NCT06722170Recruiting
Gene therapy study for hearing loss caused by OTOF gene mutation
This trial tests a gene therapy called EH002 for people with severe or profound hearing loss due to changes in the OTOF gene. The treatment aims to help the ear hear better by replacing the faulty gene.
Zhengzhou, HenanAges 6 months+ - NCT05402813Recruiting
Study of hearing loss in children with GJB2 or OTOF gene changes
This study follows children with hearing loss caused by changes in specific genes (GJB2 or OTOF). It helps researchers understand how hearing develops over time and how children may do with or without cochlear implants.
ParisAges Up to 16 years - NCT07288580RecruitingPhase 1/Phase 2
Gene therapy for children with inherited deafness
This trial tests an injection called EHT102 for children who have severe or profound hearing loss due to mutations in the Otoferlin gene. The goal is to see if the treatment can restore or improve hearing.
Shanghai, Shanghai MunicipalityAges 1–17 - NCT07282028RecruitingPhase 2/Phase 3
Spectacle hearing aid study for adults with mild to moderate hearing loss
This study tests a new hearing aid built into glasses for people who have mild to moderate hearing trouble, especially in noisy places. It aims to see if the glasses help you hear better without needing a traditional hearing aid.
Tel AvivAges 18 years+ - NCT07335874Recruiting
Hearing screening follow-up for congenital infection in newborns
This study checks if babies who fail their newborn hearing test might have a hidden infection from birth. It looks for cytomegalovirus (CMV), a common virus that can affect hearing, using a simple test.
StrasbourgAges birth–1 month - NCT06226558Recruiting
Long-Term Health of Children with Congenital CMV in NY
This study will follow children born in New York State who were tested for cytomegalovirus (CMV) as newborns. It aims to understand their long-term health and development, whether they were confirmed to have CMV, a false positive, or even a late detection if born early.
Stony Brook, New YorkAges birth–1 year - NCT06229717Recruiting
Balance and hearing study for children with hearing loss
This study looks at how hearing loss affects balance in children aged 3 to 10. It tests balance and inner ear function to help understand the connection between hearing and balance problems.
HerningAges 3–10 - NCT07298499Enrolling by invitation
Hearing aids and sound therapy for tinnitus
This trial tests using hearing aids with built-in tinnitus maskers to see if they help adults who have both hearing loss and ringing in the ears. It aims to find out if these devices improve hearing and reduce tinnitus symptoms.
Broomfield, ColoradoAges 18 years+ - NCT01793168Recruiting
Rare disease registry and history study
This study keeps a registry (a structured list) of people with rare diseases and may also track how the condition changes over time. It can help researchers better understand rare illnesses and find gaps in care, which may improve future treatments.
Sioux Falls, South DakotaAges Any age - NCT07572357Recruiting
Testing a New Self-Fit Hearing Aid with a Smartphone App
This study evaluates the RH210 hearing aid, which you fit yourself using a smartphone app. It's designed for people with mild-to-moderate hearing loss who want a simpler, app-based approach to managing their hearing.
Macquarie Park, New South WalesAges 18 years+ - NCT07252492Recruiting
Testing a new hearing device for people with hearing loss
This study tests a new hearing device called 'Audiocap' to see if it helps people with mild to moderate hearing loss hear better. It may be an option if you are getting your first hearing aid.
Lyon, FranceAges 18 years+ - NCT07635368Recruiting
Blood Markers in Newborns With CMV Infection
This research study examines blood samples from newborns to identify biological markers (proteins and genetic signals) that could help detect and understand congenital cytomegalovirus (CMV) infection—a virus some babies are born with. Finding these markers might help doctors identify infected infants earlier and develop better treatments.
CopenhagenAges birth–4 weeks - NCT06248398Recruiting
Robot-assisted cochlear implant and hearing in noise
This trial tests whether a robot-assisted cochlear implant surgery improves how well you hear speech in noisy environments. If you have severe hearing loss in both ears and are a candidate for a cochlear implant, this study may help show if the robotic method leads to better hearing outcomes.
ParisAges 18 years+ - NCT04240561Recruiting
Study of hearing aid results in people with Alzheimer’s dementia
This study looks at how much hearing aid outcomes vary in older adults who have Alzheimer’s dementia or mild memory problems. It may help researchers understand what hearing aids work best and for whom.
Chicago, IllinoisAges 50–90 - NCT06237790Recruiting
Comparing speech understanding: gene therapy vs. cochlear implant
This study compares how well people with severe hearing loss from birth understand speech after either gene therapy (which fixes a faulty gene) or a cochlear implant (a device that helps you hear). It includes healthy people with normal hearing as a comparison group, and it aims to see which treatment works better for understanding spoken language.
Beijing, Beijing MunicipalityAges 6 months+ - NCT07011927Recruiting
Testing a new electrode placement during cochlear implant surgery
This study is testing a safe way to place an extra electrode near a nerve in your ear during cochlear implant surgery. The goal is to see if this can improve hearing outcomes.
New York, New YorkAges 18 years+ - NCT05870527Enrolling by invitation
Pupil changes during vagus nerve stimulation during ear surgery
This study looks at how your pupils (the black center of the eye) respond while a vagus nerve device is turned on during surgery for either a cochlear implant or a vagus nerve stimulator. It aims to better understand the eye/nerve effects of this stimulation, which may improve how such procedures are done safely.
New York, New YorkAges 18 years+
Hear when a new Congenital Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for congenital hearing loss?
- Yes. Clin2 currently lists 22 recruiting congenital hearing loss studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a congenital hearing loss trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a congenital hearing loss trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.